{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T04:09:10Z","timestamp":1761192550975,"version":"build-2065373602"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,22]]},"DOI":"10.7759\/cureus.95195","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T04:04:42Z","timestamp":1761192282000},"source":"Crossref","is-referenced-by-count":0,"title":["Misoprostol Versus Oxytocin for Labor Induction in Term Prelabor Rupture of Membranes: A Systematic Review of Their Efficacy and Safety"],"prefix":"10.7759","author":[{"given":"Mona Sidahmed","family":"Hassan Abdalla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Hamid","family":"El Hassan Hamid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Egbal Lutfi","family":"Mohamed Salih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reem Babkir","family":"Altayeb Abdullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya Sidahmed","family":"Hassan Abdalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tabareh Saifaldeen","family":"Abdulla Awadalkarem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roaa Fathi","family":"Ali Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima Babikir","family":"Awadalseed Basheer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1515\/jpm-2017-0027","article-title":"Mid-trimester preterm premature rupture of membranes (PPROM): etiology, diagnosis, classification, international recommendations of treatment options and outcome","volume":"46","author":"Tchirikov M","year":"2018","unstructured":"Tchirikov M, Schlabritz-Loutsevitch N, Maher J, Buchmann J, Naberezhnev Y, Winarno AS, Seliger G. Mid-trimester preterm premature rupture of membranes (PPROM): etiology, diagnosis, classification, international recommendations of treatment options and outcome. J Perinat Med. 2018, 46:465-88. 10.1515\/jpm-2017-0027","journal-title":"J Perinat Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/0049475519886447","article-title":"Neonatal complications in women with premature rupture of membranes (PROM) at term and near term and its correlation with time lapsed since PROM to delivery","volume":"50","author":"Gupta S","year":"2020","unstructured":"Gupta S, Malik S, Gupta S. Neonatal complications in women with premature rupture of membranes (PROM) at term and near term and its correlation with time lapsed since PROM to delivery. Trop Doct. 2020, 50:8-11. 10.1177\/0049475519886447","journal-title":"Trop Doct"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogc.2020.02.111","article-title":"Oral misoprostol for induction of labour in term PROM: a systematic review","volume":"42","author":"Padayachee L","year":"2020","unstructured":"Padayachee L, Kale M, Mannerfeldt J, Metcalfe A. Oral misoprostol for induction of labour in term PROM: a systematic review. J Obstet Gynaecol Can. 2020, 42:1525-31. 10.1016\/j.jogc.2020.02.111","journal-title":"J Obstet Gynaecol Can"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2023.06.041","article-title":"Oxytocin: physiology, pharmacology, and clinical application for labor management","volume":"230","author":"Hermesch AC","year":"2024","unstructured":"Hermesch AC, Kernberg AS, Layoun VR, Caughey AB. Oxytocin: physiology, pharmacology, and clinical application for labor management. Am J Obstet Gynecol. 2024, 230:S729-39. 10.1016\/j.ajog.2023.06.041","journal-title":"Am J Obstet Gynecol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2021.09.003","article-title":"Misoprostol for labour induction","volume":"77","author":"Kumar N","year":"2021","unstructured":"Kumar N, Haas DM, Weeks AD. Misoprostol for labour induction. Best Pract Res Clin Obstet Gynaecol. 2021, 77:53-63. 10.1016\/j.bpobgyn.2021.09.003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.04.226","article-title":"Induction of labor at term with vaginal misoprostol or a prostaglandin E2 pessary: a noninferiority randomized controlled trial","volume":"225","author":"Gaudineau A","year":"2021","unstructured":"Gaudineau A, Senat MV, Ehlinger V, et al.. Induction of labor at term with vaginal misoprostol or a prostaglandin E2 pessary: a noninferiority randomized controlled trial. Am J Obstet Gynecol. 2021, 225:542.e1-8. 10.1016\/j.ajog.2021.04.226","journal-title":"Am J Obstet Gynecol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0304631","article-title":"Comparing labour induction outcomes using misoprostol and dinoprostone in term pregnancies: a retrospective study at Kiambu Level 5 Hospital between 2018 and 2020","volume":"19","author":"Mwancha-Kwasa M","year":"2024","unstructured":"Mwancha-Kwasa M, Admani R, Mbuga M, et al.. Comparing labour induction outcomes using misoprostol and dinoprostone in term pregnancies: a retrospective study at Kiambu Level 5 Hospital between 2018 and 2020. PLoS One. 2024, 19:e0304631. 10.1371\/journal.pone.0304631","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:l4898. 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2024.101414","article-title":"Oxytocin vs oral misoprostol for PROM induction in nulliparas with unfavorable cervix: a randomized trial","volume":"6","author":"Bender WR","year":"2024","unstructured":"Bender WR, Mccoy JA, Levine LD. Oxytocin vs oral misoprostol for PROM induction in nulliparas with unfavorable cervix: a randomized trial. Am J Obstet Gynecol MFM. 2024, 6:101414. 10.1016\/j.ajogmf.2024.101414","journal-title":"Am J Obstet Gynecol MFM"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-023-01290-0","article-title":"Oxytocin versus oral misoprostol for induction of labor in pregnant women with term prelabor rupture of membranes: a randomized clinical trial","volume":"30","author":"Ahmed RH","year":"2023","unstructured":"Ahmed RH, Sweed MS, El-Bishry GA, Hassan RK. Oxytocin versus oral misoprostol for induction of labor in pregnant women with term prelabor rupture of membranes: a randomized clinical trial. Reprod Sci. 2023, 30:3507-14. 10.1007\/s43032-023-01290-0","journal-title":"Reprod Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9449036","article-title":"Sublingual misoprostol versus oxytocin to induce labor in term premature rupture of membranes in pregnant women: a randomized single\u2010blind controlled trial","volume":"2022","author":"Unthanan S","year":"2022","unstructured":"Unthanan S, Petcharat K, Prommas S, Smanchat B, Bhamarapravatana K, Suwannarurk K. Sublingual misoprostol versus oxytocin to induce labor in term premature rupture of membranes in pregnant women: a randomized single\u2010blind controlled trial. Biomed Res Int. 2022, 2022:9449036. 10.1155\/2022\/9449036","journal-title":"Biomed Res Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.21608\/aimj.2022.138384.1947","article-title":"Oxytocin versus vaginal misoprostol for induction of labour in pregnant women with term pre-labour rupture of membranes","volume":"3","author":"Muhmed SA","year":"2022","unstructured":"Muhmed SA, Abdelmoaty MA. Oxytocin versus vaginal misoprostol for induction of labour in pregnant women with term pre-labour rupture of membranes. Al-Azhar Intern Med J. 2022, 3:91-7. 10.21608\/aimj.2022.138384.1947","journal-title":"Al-Azhar Intern Med J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20200868","article-title":"Oxytocin versus Misoprostol used as an induction of labour in term in early rupture of amniotic membranes","volume":"3","author":"Bhatu JJ","year":"2020","unstructured":"Bhatu JJ, Chaudhari AB, Chauhan NR. Oxytocin versus Misoprostol used as an induction of labour in term in early rupture of amniotic membranes. Int J Reprod Contracept Obstet Gynecol. 2020, 3:1023-9. 10.18203\/2320-1770.ijrcog20200868","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.21608\/ebwhj.2020.20284.1060","article-title":"Oxytocin versus sublingual misoprostol for induction of labour in term prelabour rupture of membranes: a randomized controlled trial","volume":"10","author":"Abdel-Aal NK","year":"2020","unstructured":"Abdel-Aal NK, Saad AS, Yehia W. Oxytocin versus sublingual misoprostol for induction of labour in term prelabour rupture of membranes: a randomized controlled trial. Evid Based Womens Health J. 2020, 10:291-7. 10.21608\/ebwhj.2020.20284.1060","journal-title":"Evid Based Womens Health J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3310\/hta20650","article-title":"Which method is best for the induction of labour? A systematic review, network meta-analysis and cost-effectiveness analysis","volume":"20","author":"Alfirevic Z","year":"2016","unstructured":"Alfirevic Z, Keeney E, Dowswell T, et al.. Which method is best for the induction of labour? A systematic review, network meta-analysis and cost-effectiveness analysis. Health Technol Assess. 2016, 20:1-584. 10.3310\/hta20650","journal-title":"Health Technol Assess"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000941.pub2","article-title":"Vaginal misoprostol for cervical ripening and induction of labour","volume":"2010","author":"Hofmeyr GJ","year":"2010","unstructured":"Hofmeyr GJ, G\u00fclmezoglu AM, Pileggi C. Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev. 2010, 2010:CD000941. 10.1002\/14651858.CD000941.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2008.01872.x","article-title":"Comparison of sublingual versus vaginal misoprostol for the induction of labour: a systematic review","volume":"115","author":"Souza AS","year":"2008","unstructured":"Souza AS, Amorim MM, Feitosa FE. Comparison of sublingual versus vaginal misoprostol for the induction of labour: a systematic review. BJOG. 2008, 115:1340-9. 10.1111\/j.1471-0528.2008.01872.x","journal-title":"BJOG"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1742749","article-title":"Technical refinements with the use of biologic healing agents","volume":"36","author":"Dibbs RP","year":"2022","unstructured":"Dibbs RP, Depani M, Thornton JF. Technical refinements with the use of biologic healing agents. Semin Plast Surg. 2022, 36:8-16. 10.1055\/s-0042-1742749","journal-title":"Semin Plast Surg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003101","article-title":"Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term","volume":"4","author":"Kelly AJ","year":"2003","unstructured":"Kelly AJ, Kavanagh J, Thomas J. Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term. Cochrane Database Syst Rev. 2003, 4:CD003101. 10.1002\/14651858.CD003101","journal-title":"Cochrane Database Syst Rev"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.midw.2020.102865","article-title":"Maternal and child healthcare in India during COVID-19 pandemic","volume":"92","author":"Paul P","year":"2021","unstructured":"Paul P, Mondal D. Maternal and child healthcare in India during COVID-19 pandemic. Midwifery. 2021, 92:102865. 10.1016\/j.midw.2020.102865","journal-title":"Midwifery"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/426576-misoprostol-versus-oxytocin-for-labor-induction-in-term-prelabor-rupture-of-membranes-a-systematic-review-of-their-efficacy-and-safety","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T04:04:43Z","timestamp":1761192283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/426576-misoprostol-versus-oxytocin-for-labor-induction-in-term-prelabor-rupture-of-membranes-a-systematic-review-of-their-efficacy-and-safety"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.95195","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,22]]}}}